ABUS
Arbutus Biopharma Corp
4.30$
-4.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -125.2% | – | +342.1% | +563.3% | -63.2% | -43.3% | -13.4% | +27.6% | +5.7% | -59.5% | -3.8% | +368.8% | -47.1% | -7.8% | +1.5% | +0.6% | +56.7% | -11.4% | +10.2% | +43.4% | -4.0% | +292.4% | +13.2% | -58.2% | +4.9% | +7.1% | -30.4% | +0.2% | -54.0% | -28.6% | +12.7% | -22.4% | +17.6% | +12.1% | +508.8% | -95.1% | +98.7% | +16,943.4% | -99.4% | – | |
| – | +9.0% | -19.1% | +11.3% | +0.6% | +14.7% | -21.7% | +17.3% | +1.3% | -33.2% | +33.0% | -13.4% | +39.2% | -30.0% | -16.1% | +0.5% | +15.3% | +35.9% | -15.9% | +14.6% | +5.8% | +15.0% | -97.9% | -2.8% | -10.4% | +6,590.7% | -98.5% | +2.4% | +7.9% | +4,659.9% | -12.3% | -97.7% | – | – | +1.7% | -99.9% | +0.0% | +0.0% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -579.2% | – | +13.2% | -58.2% | -380.6% | – | -30.4% | +0.2% | -431.0% | – | +12.7% | -22.4% | -640.4% | – | – | -95.2% | +100.8% | +17,122.6% | -99.4% | – | |
| – | +9.0% | -19.1% | +11.3% | +0.6% | +14.7% | -21.7% | +17.3% | +1.3% | -33.2% | +33.0% | -13.4% | +39.2% | +217.3% | -81.5% | +0.5% | +15.3% | +35.9% | -15.9% | +14.6% | +5.8% | +15.0% | -3.9% | +24.3% | -12.6% | +14.4% | -20.4% | -3.2% | +14.0% | -12.9% | -12.3% | +1.0% | -8.2% | -38.3% | +1.7% | -38.6% | +5.1% | -13.4% | -17.7% | -29.7% | – | |
| – | +27.2% | -8.6% | +6.3% | -20.4% | -3.2% | +3.6% | +2.9% | -30.3% | +125.3% | -25.6% | +85.6% | -60.3% | -42.2% | +89.3% | +0.4% | +14.0% | -9.9% | +5.9% | +15.5% | -6.6% | +9.9% | +6.4% | +6.3% | -32.8% | +21.6% | +30.7% | +7.7% | -2.3% | -12.7% | +4.1% | +42.1% | -39.9% | +85.8% | -30.8% | -42.9% | -8.5% | +21.2% | +59.3% | -34.2% | – | |
| – | +12.5% | -16.6% | +10.7% | -3.6% | +11.1% | -17.1% | +13.7% | -4.9% | -11.2% | +12.2% | +9.2% | +0.2% | -89.6% | +88.9% | -0.8% | +11.6% | -50.9% | +74.6% | +29.1% | +320.5% | -78.0% | +391.8% | +20.4% | -16.2% | -75.3% | +311.4% | -4.4% | +13.8% | -79.7% | +292.2% | +11.6% | -2.3% | -70.6% | +310.1% | -66.3% | -4.8% | -1.4% | +15.1% | -30.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -657.3% | – | – | -103.5% | – | |
| – | -32.5% | -85.4% | +61.9% | +11.8% | -1.3% | +38.7% | +674.0% | -6.1% | -83.9% | -90.2% | -83.3% | +54,900.0% | -9.6% | +4.7% | +5.6% | -2.3% | -25.8% | -3.1% | -1.2% | -0.1% | -26.5% | -9.6% | -4.7% | -11.0% | -28.0% | -35.9% | -13.6% | -73.1% | -4.3% | +0.0% | -22.7% | -14.7% | +3.4% | -6.7% | +0.0% | -17.9% | -21.7% | -5.6% | +5.9% | – | |
| – | – | – | – | – | – | – | – | -1,030.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -406.9% | – | – | -103.0% | – | |
| – | -11,249.4% | – | – | -168.0% | – | – | -2,489.6% | – | – | – | – | – | – | – | +5.6% | -233.8% | – | -3.1% | -1.2% | -0.1% | -26.5% | +693.6% | -98.1% | -394.0% | – | -189.5% | – | -315.8% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -891.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -406.9% | – | – | -103.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -400.9% | – | – | -103.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.